The webinar Structural Aspects of Antimicrobial Peptides and Antimicrobials was organized on 11 May 2023, by MDPI and the journal Antibiotics (ISSN: 2079-6382). The webinar focused on presenting and discussing important findings regarding the structure–activity relationship (SAR) of antimicrobial molecules, including AMPs, but also other natural, synthetic or repurposed antimicrobial compounds.

Please note that this webinar is associated with a Special Issue in Antibiotics entitled “Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials”, which has a deadline of 31 July 2023, and “Discovery and MultiFunctionality of Anti-Microbial Peptides”, which has a deadline of 31 December 2023.

You can watch the recorded webinar at the following link:

Webinar Chair and Keynote Speakers:

• Dr. Marc Maresca, Marseille Université, Marseille, France;
• Prof. Marc Devocelle, Royal College of Surgeons in Ireland, Dublin, Ireland;
• Prof. Aurélie Tasiemski, Institut Pasteur de Lille, Lille, France;
• Prof. Gregory N. Tew, University of Massachusetts Amherst, Amherst MA, United States.

FEMS was established in 1974 and is now an active and diverse federation of 55 European learned societies that includes around 30,000 professionals who are committed to advancing microbiology for the benefit of society. Located in 38 European countries, around half of these professionals are early career researchers, and the remainder include industry scientists, established academics, educators and campaigners. The 10th FEMS Congress of European Microbiologists will take place in Hamburg, Germany, from 9 to 13 July 2023. This event is dedicated to showcasing the latest developments in microbiology and to connecting microbiologists from all over the world.

Main topics:

• Environmental Microbiology & Ecology;
• Biotechnology & Synthetic Microbiology; 
• Food Microbiology; 
• Infection Biology & Pathogens; 
• Infectious Diseases; 
• Taxonomy & Systematics;
• Genetics & Genomics;
• Virology;
• Microbiology Education & Profession;
• Molecular Microbiology & Biochemistry.

The following MDPI journals will be represented:

• Microorganisms;
• Veterinary Sciences;
• Foods;
• MPs;
• CIMB;
• Diversity;
• Biology;
• Fermentation;
• Microbiology Research;
• JoF;
• Pathogens;
• Antibiotics;
• Biomolecules.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth #B18 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://www.fems2023.org/.

The world is facing an important challenge regarding the fight against multi-drug resistant microorganisms. According to the World Health Organization (WHO), infection by microorganisms resistant to available antibiotics and antimicrobials may lead to millions of deaths every year by 2050 if advances are not made.

Various molecules have been explored as potential replacements and/or adjuvants to conventional antimicrobials. Among them, antimicrobial peptides (AMPs) and other antimicrobial polymers seem very promising due to their membranolytic activity, leading to fast and selective killing, limiting the development of resistance. In addition, contrary to conventional antibiotics, AMPs possess additional activities (including antiviral, antifungal, anticancer, anti-inflammatory and/or wound healing activities), making them able to potentially fight many human diseases. Indeed, many AMPs have already been used in medicine or tested in clinical trials.

The urgency to find a new antimicrobial treatment has also led to the characterization of hundreds of natural or synthetic molecules and the repurposing of molecules that were not initially identified as antimicrobial ones.

The objective of the webinar series “Structural Aspects of Antimicrobial Peptides and Antimicrobials” is to present and discuss important findings regarding the structure–activity relationship (SAR) of antimicrobial molecules, including AMPs, but also other natural, synthetic, or repurposed antimicrobial compounds.

Date: 11 May 2023 at 4:00 p.m. CEST | 10:00 a.m. EDT | 10:00 p.m. CST Asia

Webinar ID: 832 0818 6949

Register now for free!

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

• Dr. Marc Maresca, Aix Marseille Université, Marseille, France;
• Prof. Marc Devocelle, Royal College of Surgeons in Ireland, Dublin, Ireland;
• Prof. Aurélie Tasiemski, Institut Pasteur de Lille, Lille, France;
• Prof. Gregory N. Tew, University of Massachusetts Amherst, Amherst MA, United States.

Relevant Special Issue:

“Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials”
Guest Editors: Prof. Dr. J. Michael Conlon, Dr. Marc Maresca and Prof. Dr. Bong-Jin Lee
Deadline for manuscript submissions: 31 July 2023

“Discovery and MultiFunctionality of Anti-Microbial Peptides”
Guest Editors: Dr. Marc Maresca, Prof. Josette Perrier and Dr. Michael Lafond
Deadline for manuscript submissions: 31 December 2023

The 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023) will be held in Houston, USA, from 15 to 19 June 2023. This annual meeting is the largest gathering of microbiologists in the world, and it is expected that nearly 8,000 professionals from all over the world will attend the meeting. Founded in 1899, the American Society for Microbiology (ASM) is the oldest and largest single life science society in the world, consisting of more than 50,000 scientists and health professionals, of which more than one-third of the members are from countries and regions outside the United States. The mission of the American Society for Microbiology is to promote and advance the science of microbiology.

Topics include:

• Disaster Microbiology;
• Emerging Infections – What is the next pandemic? (Focus on Nipah and Marburg);
• Natural Product Discovery and Synthesis;
• Combating the Climate Crisis with Critters: Microbial Carbon Capture;
• Powering the Future: Applied Microbiology in the Energy Industry;
• Equity and Access in Laboratory Diagnostics;
• Microbiome Management in a Changing World.

The following MDPI journals will be represented:

• Microorganisms;
• Journal of Fungi;
• Viruses;
• Applied Biosciences;
• MPs;
• IJMS;
• Vaccines;
• Fermentation;
• Diversity;
• Metabolites;
• Biomolecules;
• Antibiotics;
• Pathogens;
• Life.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth number #2504 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://asm.org/Events/ASM-Microbe/Home.

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

To develop different research areas and continue to attract high-quality papers, Antibiotics (ISSN: 2079-6382) is recruiting Section Editors-in-Chief for the following Sections:

• Fungi and Their Metabolites;
• Antibiotics in Animal Health.

The main responsibilities of the Section Editors-in-Chief are as follows:

• Supervising the quality of the papers in their Section (when we have new submissions to the Section);
• Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
• Providing any conference/society cooperation recommendations.

This position is open to experts on related aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or the Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN: 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to, the following: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. The Impact Factor for Antibiotics (2021) is 5.222; ranking 68/279 (Q1) in the "Pharmacology & Pharmacy" category and 39/94 (Q2) in the "Infectious Diseases" category.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are currently recruiting Editorial Board Members (EBMs) for MDPI journals indexed in the Emerging Sources Citation Index (ESCI) in Web of Science. In particular, we are looking for experts who are interested in aiding in the development of our journals and safeguarding the scientific quality of the published findings.

Journals currently listed in the ESCI will receive an Impact Factor in June 2023, according to the changes announced by Web of Science (Clarivate). Therefore, this is an excellent time to become an Editorial Board Member for one of these fast-developing journals.

If you are interested in sharing your expertise in one of the journals listed below, please send us an application using this link.

The Editorial Office of the journal will contact you once the application has been approved.
Editorial Board Members are responsible for academic decisions on manuscripts in their field of expertise, will edit Special Issues, and may be invited to review manuscripts. The initial term lasts for two years, after which it can be renewed, and entails the following:

• Prescreening and making decisions on new submissions related to your research interests;
• Setting up at least one Special Issue during your term on a topic related to your research interests (or supervising Special Issues related to your research field);
• Providing input or feedback regarding journal policies;
• Helping to promote the journal among your peers or at conferences;
• Attending Board meetings to suggest journal development strategies;
• Reviewing manuscripts.

Editorial Board Members are entitled to a full waiver on one publication per year in the journal that they serve and need to be experts in their fields.

The list of ESCI journals can be found here: https://www.mdpi.com/about/journals/esci.

Please find the list of ESCI journals, categorized by subject, for which we are recruiting Editorial Board Members below.

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

MDPI will be attending EuroBioFilms 2022 (EBF), hosted by the ESCMID Study Group for Biofilms (ESGB), which will be held from 31 August to 3 September 2022 in Palma de Mallorca, Spain. The conference will be held at the Meliá Palma Marina Hotel, Av. de Gabriel Roca, 29, 07014 Palma, Balearic Islands.

The multidisciplinary program will cover many subjects and will be a mix of basic and clinical biofilm-related topics. Leading scientists in the field will be present as keynote speakers and/or chairpersons. Oral presentations will be presented during various parallel sessions. On 31^st of August, several educational preconference workshops will be organized.

The following MDPI journals will be represented:

• Antibiotics (leading);
• Pathogens;
• Membranes;
• Biology;
• Journal of Personalized Medicine.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following link: https://eurobiofilms2022.com/, or contact the Antibiotics Editorial Office at antibiotics@mdpi.com.

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Source: 2021 CiteScores™ (Elsevier)

We are pleased to announce the launch of a new initiative, the Special Issue Mentor Program.

This program intends to provide an opportunity for early-career scientists to enhance their editing, networking, and organizational skills, and to work closely with our journal to gain more editorial experience. Early-career scientists who have novel ideas for new Special Issues in Antibiotics (ISSN: 2079-6382) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of Antibiotics or from other well-established research institutes or laboratories.

If you are interested in this opportunity, please send your Special Issue proposal to the Antibiotics Editorial Office (antibiotics@mdpi.com), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, Antibiotics will continue to welcome all Special Issue proposals based on hot research topics.

The Sections “Antibiotics in Animal Health”, “Antibiotic Therapy in Infectious Diseases”, “Antimicrobial Materials and Surfaces” and “Antibiofilm Strategies” were launched recently to provide a platform for related articles and improve our competitiveness. Now we are recruiting Editorial Board Members for these new Sections, and we look forward to your applications.

The main responsibilities of the Section Editorial Board Members are as follows:

• Supervising the quality of papers in the Section (when we have new submissions to the Section);
• Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
• Providing any conference/society cooperation recommendations.

This position is open to experts on antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science.

We are pleased to announce that Dr. Krisztina M. Papp-Wallace from the Louis Stokes Cleveland VA Medical Center has been appointed Associate Editor for the journal Antibiotics (ISSN 2079-6382).

We are also pleased to announce the appointment of new Section Editors-in-Chief for recently established Sections. Dr. Serena Riela from the University of Palermo Viale delle Scienze will serve as the section Editor-in-Chief for “Antimicrobial Materials and Surfaces”; Prof. Dr. Max Maurin from the Centre Hospitalier Universitaire Grenoble Alpes will serve in this role for “Antibiotics in Animal Health”; Dr. Wolf-Rainer Abraham from the Helmholtz Centre for Infection Research will fill this position for “Antibiofilm Strategies”; and Dr. Mehran Monchi from the Centre Hospitalier de Melun will serve in this role for “Antibiotic Therapy in Infectious Diseases”.

We are confident that with the guidance of our new Associate Editor and Section Editors-in-Chief, we will continue to improve the reputation and quality of Antibiotics.

The year 2021 marks the 10th anniversary of Antibiotics (ISSN: 2079-6382), a peer-reviewed open access journal on antibiotics. Antibiotics has published more than 1500 papers by more than 8500 authors. We value the contributions made by authors and reviewers. To celebrate this 10th anniversary, we launched a series of themed Special Issues. We warmly welcome you to read these Special Issues. All articles can be accessed online for free. You are also welcome to share this message further with your peers. Please find the information regarding these Special Issues below.

Anniversary Special Issues

“10th Anniversary of Antibiotics—Feature Papers” (Edited by Prof. Dr. Nicholas Dixon)
“10th Anniversary of Antibiotics—New Resources and Strategies in the Search for Antimicrobials” (Edited by Prof. Dr. Jesus Simal-Gandara, Prof. Dr. Lillian Barros and Prof. Dr. Miguel A. Prieto Lage)
“10th Anniversary of Antibiotics - Recent Advances in Antibiotic Biosynthesis” (Edited by Prof. Dr. Manuel Simões)
“10th Anniversary of Antibiotics — Recent Advances in Rational Antimicrobial Use” (Edited by Dr. Albert Figueras)
“10th Anniversary of Antibiotics—Recent Advances in Bacteriophage Therapy” (Edited by Prof. Dr. Adelaide Almeida)
“10th Anniversary of Antibiotics—Recent Advances in Plant-Derived Antibiotics” (Edited by Prof. Dr. William N. Setzer and Dr. Noura Dosoky)
“10th Anniversary of Antibiotics—Recent Advances in Pharmacodynamics of Antibiotics” (Edited by Prof. Dr. Federico Pea)
“10th Anniversary of Antibiotics—Recent Advances in Antibiotic and Antibiotic Resistance Research in Food” (Edited by Prof. Dr. David Rodríguez-Lázaro and Dr. María Ugarte Ruiz)
“10th Anniversary of Antibiotics - Recent Advances in Novel Antimicrobial Agents” (Edited by Prof. Dr. Carlos M. Franco)
“10th Anniversary of Antibiotics–Recent Advances in Antimicrobial Peptides” (Edited by Dr. Jean-Marc Sabatier and Prof. Dr. Zhijian Cao)

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited Researchers^TM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of Science^TM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

• Have expertise and experience in the field related to the journal;
• Have received a Ph.D. in the last 10 years, approximately;
• Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
• Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

• 25 October 2021
  Energies journal and Institute of Mechanics, Chinese Academy of Sciences

• 28 October 2021
  Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University

• 29 October 2021
  Processes journal and Beijing Institute of Technology

• 29 October 2021
  Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

According to the aim and scope of the journal and the papers we are publishing, we are launching four new sections to improve our competitiveness and the strength of our editorial team. These sections are “Antibiotics in Animal Health”, “Antibiotic Therapy in Infectious Diseases”, “Antimicrobial Materials and Surfaces”, and “Antibiofilm Strategies”. We are recruiting Section Editors-in-Chief for these four sections of Antibiotics.

The main responsibilities of the Section Editors-in-Chief are as follows:

• Supervising the quality of the papers in their section (when we have new submissions to the section);
• Acting as, or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
• Providing any conference/society cooperation recommendations.

This position is open to experts on related aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open-access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category, and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science.

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

• Adriana Burlea-Schiopoiu;
• Alban Kuriqi;
• Álvaro González-Vila;
• Alessandro Alaimo;
• Alexey Beskopylny;
• Alexander Yu Churyumov;
• Alberto Fernández-Isabel;
• Andrea Mastinu;
• Antonios N. Papadopoulos;
• Anton Rassõlkin;
• Antonio Humberto Hamad Minervino;
• Arkadiusz Matwijczuk;
• Artur Słomka;
• Baojie He;
• Bartłomiej Potaniec;
• Bojan Đurin;
• Camilo Arturo Rodriguez Diaz;
• Carmelo Maria Musarella;
• Chiachung Chen;
• Chiman Kwan;
• Cristian Busu;
• Danil Pimenov;
• Dan-Cristian Dabija;
• Delfín Ortega-Sánchez;
• Demetrio Antonio Zema;
• Denis Butusov;
• Elena Lucchi;
• Gaurab Dutta;
• Livia Anastasiu;
• M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

MDPI will be attending the 2021 Chinese Medicinal Chemistry Symposium and CPA-EFMC International Symposium on Medicinal Chemistry (CMCS 2021), hosted by the Division of Medicinal Chemistry and Chinese Pharmaceutical Association, which will be held from Monday, 27 September, until Thursday, 30 September 2021, in Shenyang, China.

As a top-level biennial event in the medicinal chemistry and the related fields in China, CMCS aims to boost the information exchange and communication between peers in frontiers of medicinal chemistry and the relevant fields. According to the cooperation framework agreement signed by the Chinese Pharmaceutical Association (CPA) and the European Federation for Medicinal Chemistry (EFMC), the CPA-EFMC International Symposium on Medicinal Chemistry (CPA-EFMC ISMC) will be held concurrently.

The topics covered will include the frontiers and hotspots of medicinal chemistry and chemical biology, innovative drug research for major diseases, rational drug design strategies and new methods, lead compound discovery and optimization strategies, natural active substance discovery and structural modification, and modern drug preparation technology and innovation craft.

The following MDPI journals will be represented:

• Molecules;
• Antibiotics;
• Medical Sciences.

If you are also attending this conference, please feel free to stop by our booth (#16). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://cmcs2021.syphu.edu.cn/Home.htm.

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category, and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science. We wouldn’t have made such progress without your valuable suggestions and support.

The main responsibilities of the Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conference/society cooperation recommendations.

This position is open to experts on all aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Sections of Antibiotics

1. Antibiotics Use and Antimicrobial Stewardship
2. Novel Antimicrobial Agents
3. Antimicrobial Peptides
4. Biosynthesis and Combinatorial Approaches in Antimicrobial Discovery
5. Mechanism and Evolution of Antibiotic Resistance
6. Fungi and their Metabolites
7. Pharmacokinetics and Pharmacodynamics of Drugs
8. Plant-Derived Antibiotics
9. Mechanisms of Antibiotic Action
10. Structures of Bacterial Proteins
11. Biochemical and Genetics Studies of Infectious Disease Progression and Intervention
12. Bacteriophages
13. The Global Need for Effective Antibiotics
14. Antibiotic Therapy in Infectious Diseases
15. Antimicrobial Materials and Surface
16. Antibiofilm Strategies
17. Antibiotics in Animal Health

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Antibiotics:

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

• 10 journals received their first impact factor
• 96% of journals increased their impact factor from 2019
• 32 journals (38%) ranked among the top 25% of journals, in at least one category

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/92 (Q2) in 'Infectious Diseases' and 75/275 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendation.

This position is open to experts on all aspects of the mechanism and evolution of antibiotic resistance. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/92 (Q2) in 'Infectious Diseases' and 75/275 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendations.

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/93 (Q2) in 'Infectious Diseases' and 75/270 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendations.

This position is open to experts on all aspects of antibiotic use and antimicrobial stewardship. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open-access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 3.893 (2019), ranking 23/93 (Q1) in 'Infectious Diseases' and 64/270 (Q1) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Associate Editor are as follows:

1. Selecting additional renowned scientists to join the Editorial Board if you feel that some areas are not yet sufficiently covered;
2. To overview the editorial process, decide whether a paper can enter the peer-review process, and decide whether it can be published after peer-review and revisions (you will feel free to appoint Associate Editors if you feel this task is too demanding);
3. To decide/recommend the topics and Guest Editors for Special Issues.

To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

Antibiotics is recruiting scholars who would like to serve as Editors-in-Chief in the new section, “Antibiotic Biosynthesis”. If you are interested in this position or would like to recommend potential candidates, please contact us at antibiotics@mdpi.com.

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

• eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
• creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
• promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
• raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
• supporting our members in achieving diversity and inclusion within their organizations.

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.

2) In the main text, there is a blank column on the left.

3) Small tables/figures are aligned on the left, large tables/figures are centered.

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

Dear scientists, researchers, and authors,

We are pleased to announce that The 1st International Electronic Conference on Antibiotics—The Equal Power of Antibiotics and Antimicrobial Resistance(ECA2021), chaired by Prof. Dr. John E. Gustafson, will be held on https://eca2021.sciforum.net from 8 to 17 May 2021.

This conference aims to provide leading scientists working in the field of antibiotics with a robust common platform through which to share and discuss the latest research and to promote the advancement of this exciting and rapidly changing field. We hope to encourage discovery across the discipline as we cover the following four broad themes in sessions A–E, as listed below:

• Antimicrobial Resistance Mechanisms and Intrinsic Microbial Factors Contributing to Resistance;
• Antimicrobial Development, Stewardship and Susceptibility Testing;
• The Epidemiology and Prevention of Infections Caused by Antimicrobial-Resistant Pathogens: Future Threats;
• Antiviral Therapies: Impact in the New Era of the COVID-19 Pandemic;
• Poster;

We are pleased to invite the global community of scholars to join ECA2021 to present their latest antibiotics research and development and share novel ideas on the multidisciplinary aspects of the research and development of antibiotics and antimicrobial resistance-related topics. Thanks to the flexibility of our innovative electronic platform, you are welcome to both upload and present your work and to attend the conference completely free of charge. We are also considering creating a Special Issue for selected conference papers in our journal Antibiotics (ISSN 2079-6382, IF 3.893, https://www.mdpi.com/journal/antibiotics). Papers published in this Special Issue, should one be launched, would receive a 30% discount on the article processing charge.

ECA2021 offers you the opportunity to participate in an international scholarly conference without the concerns and expense of travelling—all you need is access to the Internet. During the conference period, you will be able to upload papers, posters, presentations (including videos) and comment on other presentations, as well as engage with fellow scholars in real time. In this way, the conference offers a novel opportunity to exchange opinions and views within the scholarly community and to discuss the papers and latest research in a discussion forum. Abstracts (in English) should be submitted by 28^th February 2021 online in the section “Conference Calls” (https://eca2021.sciforum.net). After abstracts are accepted, please submit the full paper by 1^st April 2021. The conference itself will be held from 8 to 17 May 2021. We hope that you will be able to join this exciting event which is organized and sponsored by MDPI, a scholarly open access publisher (https://www.mdpi.com/). Paper Submission Guidelines: For information about the procedure for the submission, peer-review, revision and acceptance of conference proceedings papers, please refer to the section "Instructions for Authors" at: https://eca2021.sciforum.net.Timeline:Abstract Submission: 28^th February 2021 Notification of Acceptance: 15^th March 2021

Proceedings Paper Submission Deadline: 1^st April 2021

Conference Date: 8–17 May 2021

We look forward to receiving your research papers and to welcoming you to the electronic conference.

Please do not hesitate to contact us if you have any questions.

Kind regards,

ECA Secretary
Ms. Hellen Wang
MDPI Branch Office, Beijing
E-Mail: eca2021@mdpi.com

MDPI is pleased to announce its participation in supporting the Resource Identification Initiative. This project is aimed at improving traceability, reproducibility and reuse of materials reported in Life Sciences literature. Resources such as antibodies, cell lines, model organism and other tools (software and databases) are assigned unique searchable Research Resource Identifiers (RRIDs), used for referencing purposes. Readers can then easily identify the resources cited, vendors and also other articles that report the same resource in a simple and convenient manner. MDPI strongly encourages authors in the fields of Life Sciences and Biomedical research to cite materials using the RRID identifiers.

Finding or Requesting an RRID:

• RRIDs can be found on the Resource Identification Portal by entering your search terms in the search bar at the top of the page. Also provided are search tips to help you quickly identify the resource of your choice.
• The RRID and identifier (for example “RRID:AB_90755”) can be directly inserted in your manuscript.
• If you cannot find your resource listed, you can easily add it by following this link: https://scicrunch.org/resources/about/resource.

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact helen.dobson@jisc.ac.uk.

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at ioap@mdpi.com.

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

• Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
• 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
• Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
  
  

First Impact Factors

Updated Impact Factors